Displaying 1 - 20 of 56
Ricardo A. Murillo, In the Matter of
Erin Thompson, In the Matter of
Larry Rickman Overly, In the Matter of
Vance Childers, In the Matter of
Eusabio Juarez-Ruffino, In the Matter of
Jason Scott, DVM, In the Matter of
Craig Lewis, In the Matter of
Jena Antonucci, In the Matter of
Philip Serpe, In the Matter of
Dr. Donald McCrosky, In the Matter of
William E. March, In the Matter of
Dr. Michael J. Galvin, In the Matter of
Zvi Kriple, In the Matter of
Edwards Lifesciences Corp. and JenaValve Technology, Inc., In the Matter of
The Federal Trade Commission issued an administrative complaint to block medical device supplier Edwards Lifesciences Corp.’s (Edwards) proposed acquisition of JenaValve Technology, Inc. (JenaValve) due to concerns that the acquisition would limit patient access to lifesaving medical devices used to treat a potentially fatal heart condition. On January 9, 2026, after a six-day trial, the U.S. District Court for the District of Columbia granted the FTC’s request for a preliminary injunction to temporarily prevent Edwards from acquiring JenaValve.
GTCR BC Holdings, LLC and Surmodics, Inc., In the Matter of
The Federal Trade Commission issued an administrative complaint to challenge GTCR BC Holdings, LLC’s acquisition of Surmodics, Inc., alleging that the deal, which seeks to combine the two largest manufacturers of critical medical device coatings, is anticompetitive. The FTC charges that private equity firm GTCR’s proposed acquisition of Surmodics would create a combined company controlling more than 50% of the market for outsourced hydrophilic coatings. These coatings are often used by medical device manufacturers and are applied to lifesaving medical devices such as catheters and guidewires.
The Federal Trade Commission filed an amended complaint adding the states of Illinois and Minnesota as co-plaintiffs in the Commission’s lawsuit challenging GTCR BC Holdings, LLC’s (GTCR) acquisition of Surmodics, Inc. (Surmodics). The amended complaint also adds GTCR, LLC as an additional defendant in the case.
Microsoft/Activision Blizzard, In the Matter of
The Federal Trade Commission authorized an administrative complaint against the proposed merger between Microsoft Corp. and Activision Blizzard, Inc., a video game developer that creates and publishes games such as Call of Duty, World of Warcraft, Diablo, and Overwatch. Microsoft sells the Xbox gaming console and also offers a video game subscription service called Xbox Game Pass, as well as a cloud-based video game streaming service. The agency alleges that the deal would enable Microsoft to suppress competitors to its Xbox gaming consoles and its rapidly growing subscription and cloud-gaming business. The Commission withdrew the matter from adjudication in July 2023, and returned it to adjudication on September 26, 2023. The evidentiary hearing will commence 21 days after the issuance of the district court's decision in FTC v. Microsoft.
Tempur Sealy International, Inc. and Mattress Firm Group Inc., In the Matter of
The Federal Trade Commission moved to block Tempur Sealy International, Inc.’s (Tempur Sealy) proposed $4 billion acquisition of Mattress Firm Group Inc. (Mattress Firm).
The Commission issued an administrative complaint and authorized a lawsuit in federal court to block the acquisition, alleging that Tempur Sealy—the world’s largest mattress supplier and manufacturer—will have the ability and incentive to suppress competition and raise prices for mattresses for millions of consumers once it acquires Mattress Firm.
FTC Challenges Medical Device Coatings Deal
Scott Shell, In the Matter of
Displaying 1 - 20 of 56